vx745 (Selleck Chemicals)
Selleck Chemicals is a verified supplier 
Selleck Chemicals manufactures this product 
93
Structured Review
Selleck Chemicals
vx745
Vx745, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vx745/VX-745/pmc08772740-34-49-50
Average 93 stars, based on 21 article reviews
Vx745, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vx745/VX-745/pmc08772740-34-49-50
Average 93 stars, based on 21 article reviews
vx745 - by Bioz Stars,
2026-10
93/100 stars
Images
1) Product Images from "Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation"
Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation
Journal: Biology
doi: 10.3390/biology11010121
Figure Legend Snippet: Western blot analysis of kCer-induced HaCaT cell differentiation and signaling pathway activation. ( A ) Effects of treatments (0, 1, and 10 μM kCer) on cell protein (c-Fos, p-c-Fos, p38, and p-p38) expression were measured by Western blot analysis. The blotted bands were analyzed by Image J and graphed as shown below. Bars represent the relative ratios of p-c-Fos/c-Fos, p-p38/p38, and involucrin/β-Actin. ( B ) Effects of treatment with 10 μM kCer treatment ±1.0 μM of the p38MAPK inhibitor SB203580 (p38α/p38β), BIRB796 (p38α/p38β/p38γ/p38δ), or VX745 (p38α/p38β/p38δ), respectively. Cell lysates were subjected to immunoblot analysis, followed by detection of p-c-Fos, c-Fos, p-p38, p38, and β-Actin. Immunoblot bands were analyzed by Image J, and the relative ratios of p-p38/p38 and p-c-Fos/c-Fos are graphed below. Data are presented as means ± SD ( n = 3, ** p < 0.01, * p < 0.05).
Techniques Used: Western Blot, Cell Differentiation, Activation Assay, Expressing
Related Articles
Western Blot:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Cell Differentiation:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Activation Assay:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Expressing:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Inhibition:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Cell Culture:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Staining:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Standard Deviation:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Concentration Assay:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Isolation:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Incubation:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Phospho-proteomics:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Flow Cytometry:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Fluorescence:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Control:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Multiplex Assay:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( Cytokine Assay:Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. Article Snippet: Chemicals.. The following chemicals were used for relevant inhibitor analysis: Rho pathway inhibitor I Rho kinase (ROCK) inhibitor Y-27632 (Cytoskeleton, Inc., CN069, Denver, CO, USA), Rac-1 inhibitor NSC237669 (AXN, Axon1578, Scottsdale, AZ, USA), p38 MAPK inhibitors SB203580 (AdipoGen, AG-CR1-0030, San Diego, CA, USA), BIRB796 (Selleck, S1574, Pittsburgh, PA, USA), and Article Title: p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells Article Snippet: ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.ILC2 cells were plated in 96 well plates at a density of 2500–5000 cells in 100 µl of complete RPMI media for stimulation.. Where indicated, ILC2 cells were pre-incubated with the kinase inhibitors Article Title: GADD45β loss ablates innate immunosuppression in cancer Article Snippet: BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS ( E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Article Title: GADD45β Loss Ablates Innate Immunosuppression in Cancer Article Snippet: BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).BMDMs were treated with LPS (E. coli serotype O55:B5, 100 ng/mL; Sigma-Aldrich) and mouse recombinant IFNγ (20 ng/mL; Sigma-Aldrich) or with mouse recombinant IL-4 (20 ng/mL; Peprotech) and mouse recombinant IL-13 (20 ng/mL; Peprotech).. The p38 inhibitors used were: Vx745 ( |
